altRx vs Pallas Health: Price and medication choice compared
altRx vs Pallas Health answers: which online GLP-1 option fits your needs? Quick verdict: altRx is positioned as the lower-cost compounded option, while Pallas Health emphasizes clinician choice between brand-name pens and compounded products with an all-in plan price.
See altRx pricing and start the quiz
Key differences at a glance for altRx vs Pallas Health
This comparison focuses on five distinctive differences supported by the sources: starting price and renewal cadence, access to brand-name versus compounded medications, what the price includes, telehealth and availability details, and regulatory notes about compounded drugs.
1. Starting price and renewal structure
altRx advertises a limited-offer starting price: compounded semaglutide starting at $89 per month and compounded tirzepatide at $149 per month. Pallas Health lists compounded semaglutide at $139 for the first month, then $597 every 12 weeks – a $199 per month average; compounded tirzepatide is $179 first month, then $897 every 12 weeks – a $299 per month average.
Compare Pallas Health plans and first-month pricing
2. Brand-name options versus compounded-only emphasis
Pallas Health explicitly offers clinician-selected FDA-approved brand-name GLP-1s including Wegovy, Ozempic, Zepbound, and Mounjaro, plus compounded semaglutide and tirzepatide when a brand medication is not the right fit. altRx positions itself around compounded semaglutide and compounded tirzepatide as its core offer; altRx notes its medications are compounded.
3. What the price covers
Both providers present an all-in, direct-pay approach but with different highlights. altRx states its monthly fee covers medical oversight, medication, sterile syringes, prep pads, step-by-step guidance, and free discreet 2-day delivery, with buy now, pay later options. Pallas Health says plan prices include provider care, check-ins and messaging with no membership fee and free expedited shipping; compounded plans are priced by medication rather than by milligram so titration does not change plan price.
Review altRx inclusions and membership details
4. Telehealth workflow and availability
altRx offers 100% online medical visits with a 2-minute quiz to start; a licensed provider will review your health evaluation and conduct a telehealth consultation which may be live video or asynchronous as allowed by state telehealth laws. altRx states availability to residents of all 50 U.S. states, with prescribing authority varying by state. Pallas Health is 100% online and asynchronous in most states – 43 of 50 need no video visit – but requires a video visit in seven states plus Washington, D.C. Both require a clinician’s review to determine eligibility for treatment.
5. Regulatory and practical caveats
Both sources include the same regulatory reminder: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas adds that it does not manufacture or compound medication and that compounded medication you receive may differ in appearance from site images. altRx notes prescriptions are filled by state-licensed 503A compounding pharmacies in its network.
| Criteria | altRx | Pallas Health |
|---|---|---|
| Starting compounded semaglutide price | $89/mo starting offer | $139 first month, then $199/mo avg |
| Compounded tirzepatide price | $149/mo starting offer | $179 first month, then $299/mo avg |
| Brand-name GLP-1s | No – positions around compounded options | Yes – Wegovy, Ozempic, Zepbound, Mounjaro available |
| What plan includes | Medication, medical oversight, supplies, 2-day delivery | Provider care, check-ins, messaging, expedited shipping |
| Telehealth style | 100% online; video or asynchronous per state | 100% online; asynchronous in most states, video required in some |
| Availability notes | Available to residents of all 50 states; prescribing varies by state | Eligibility determined by a US-licensed clinician; video visit required in some states |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved; Pallas does not compound |
How these differences affect choice
If price for a compounded GLP-1 is the primary factor, altRx advertises the lower advertised starting rates and emphasizes same-price-every-month promotions and buy now, pay later options. If you want a clinician to consider both brand-name pens and compounded preparations inside one program, Pallas Health presents that clinician-led choice and an all-in plan price that covers provider care and messaging.
Check Pallas Health clinician options and plan details
Conclusion: altRx vs Pallas Health
In summary, altRx vs Pallas Health splits on cost emphasis and medication pathways. altRx positions itself as the most affordable compounded program with semaglutide from $89/mo and tirzepatide from $149/mo, while Pallas Health offers clinician-selected brand-name GLP-1s plus compounded options with compounded semaglutide at $139 first month then $199/mo avg and plan pricing that includes provider care.
Choose altRx if you prioritize lower advertised starting prices for compounded semaglutide or tirzepatide and a fully online intake with free 2-day delivery.
Choose Pallas Health if you want a clinician to evaluate and offer FDA-approved brand-name pens or a compounded alternative inside one all-in plan that includes provider care and messaging.